发明名称 COMPOSICION FARMACEUTICA DE LIBERACION CONTROLADA, QUE COMPRENDE UN NUCLEO BIOADHERENTE, CONTENIENDO UN AGENTE ANTIGLUCEMIANTE Y COMO AGENTE REGULADOR DE LIBERACION CONTROLADA EL ACIDO POLIACRILICO POLIMERIZADO SIN BENCENO O SUS DERIVADOS; PROCEDIMIE
摘要 The composition, pharmaceutical form and processes in the present invention comprise a nucleus obtained by compression, having bioadherent property and gastric retention capacity, containing extended release, water-soluble anti-glucose-providing agent, also soluble in pH lower or equal to 5, having as controlled release regulating agent benzene-free polymerized polyacrylic acid or its derivatives. The nucleus may contain one or more acid-modulated coating layers with coadjuvant pharmacologically active agents, also having anti-glucose-providing effect, non-water-soluble and soluble in pH higher or equal to 5, immediate release, also comprising pharmaceutically acceptable excipients. The bioadherent nucleus allows controlled release of biguanides, preferably metformin and the coating layers allow sulphonylureas release, preferably glimepiride. The present invention allows isolated metformin release or combined release of two classes of drugs with different solubility and absorption conditions, and the volume of their final form is reduced.
申请公布号 CL2007003675(A1) 申请公布日期 2008.06.27
申请号 CL20070003675 申请日期 2007.12.18
申请人 MEDLEY S.A. INDUSTRIA FARMACEUTICA 发明人 ALEXANDRE FUNARI NEGRAO.
分类号 A61K9/22;A61K31/155;A61P3/10 主分类号 A61K9/22
代理机构 代理人
主权项
地址